Toxicity Profiling and Antihyperuricemic Activity of Goubion: A Polyherbal Formulation

Figure 5

Histopathological section of the liver: (a) female control; (b) female 15 mg/kg; (c) female 30 mg/kg; (d) female 60 mg/kg; (e) male control; (f) male 15 mg/kg; (g) male 30 mg/kg; and (h) male 60 mg/kg.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)